CLINICAL_TRIALS
trial_result
· 2022-02-17
Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Summary
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and various squamous an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tarveda Therapeutics | Conditions: Carcinoma, Endometrial Adenocarcinoma | Phase 1, Phase 2 | Status: UNKNOWN